Cargando…

MON-110 Utilization of GluCEST, a Novel Neuroimaging Technique, to Characterize the Brain Phenotype in Hyperinsulinism/Hyperammonemia Syndrome

BACKGROUND: Hyperinsulinism/Hyperammonemia (HI/HA) syndrome is the second most common form of congenital hyperinsulinism. It is caused by gain-of-function mutations in glutamate dehydrogenase (GDH), a mitochondrial enzyme expressed in pancreatic β-cells, liver, kidney, and brain, and is responsible...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenfeld, Elizabeth, Nanga, Ravi P R, Reddy, Ravinder, Revell, Andy, Roalf, David R, Davis, Kathryn A, De Leon, Diva D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209661/ http://dx.doi.org/10.1210/jendso/bvaa046.594

Ejemplares similares

Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum
por: Roalf, David R., et al.
Publicado: (2017)

Reproducibility of 2D GluCEST in healthy human volunteers at 7 T
por: Nanga, Ravi Prakash Reddy, et al.
Publicado: (2018)

Characterizing the neurological phenotype of the hyperinsulinism hyperammonemia syndrome
por: Rosenfeld, Elizabeth, et al.
Publicado: (2022)

Correction: Characterizing the neurological phenotype of the hyperinsulinism hyperammonemia syndrome
por: Rosenfeld, Elizabeth, et al.
Publicado: (2022)

Mapping hippocampal glutamate in mesial temporal lobe epilepsy with glutamate weighted CEST (GluCEST) imaging
por: Lucas, Alfredo, et al.
Publicado: (2022)

Diminished Reward Responsiveness is Associated with Lower Reward Network GluCEST: An Ultra-High Field Glutamate Imaging Study
por: Sydnor, Valerie J., et al.
Publicado: (2021)

Volumetric glutamate imaging (GluCEST) using 7T MRI can lateralize nonlesional temporal lobe epilepsy: A preliminary study
por: Hadar, Peter N., et al.
Publicado: (2021)

In vivo GluCEST MRI: Reproducibility, background contribution and source of glutamate changes in the MPTP model of Parkinson’s disease
por: Bagga, Puneet, et al.
Publicado: (2018)

Longitudinal GluCEST MRI Changes and Cerebral Blood Flow in 5xFAD Mice
por: Igarashi, Hironaka, et al.
Publicado: (2020)

Mosaic GLUD1 Mutations Associated with Hyperinsulinism Hyperammonemia Syndrome
por: Boodhansingh, Kara E., et al.
Publicado: (2022)

Glutamate Chemical Exchange Saturation Transfer (GluCEST) Magnetic Resonance Imaging in Pre-clinical and Clinical Applications for Encephalitis
por: Jia, Yanlong, et al.
Publicado: (2020)

Glutamate Chemical Exchange Saturation Transfer (GluCEST) Magnetic Resonance Imaging of Rat Brain With Acute Carbon Monoxide Poisoning
por: Xu, Yuan, et al.
Publicado: (2022)

OR05-2 Targeted Inhibition of Glutamate Dehydrogenase by Alpha-Tocopherol: A Potential Novel Treatment for Hyperinsulinism Hyperammonemia Syndrome
por: Rosenfeld, Elizabeth, et al.
Publicado: (2019)

Hyperinsulinism-hyperammonemia Syndrome in An Infant with Seizures
por: Strajnar, A, et al.
Publicado: (2018)

Hyperinsulinism Hyperammonemia Syndrome, a Rare Clinical Constellation
por: Hussain, Jonathan, et al.
Publicado: (2016)

Early Presentation of Hyperinsulinism/Hyperammonemia Syndrome in Three Serbian Patients
por: Sarajlija, Adrijan, et al.
Publicado: (2016)

New Insight in Hyperinsulinism/Hyperammonemia Syndrome by Magnetic Resonance Imaging and Spectroscopy
por: Gariani, Karim, et al.
Publicado: (2022)

MON-087 Natural History and Neurodevelopmental Outcomes in Perinatal Stress Induced Hyperinsulinism
por: Sigal, Winnie M, et al.
Publicado: (2020)

A Very Rare Case of Diabetes Mellitus Occurring in a Patient With Hyperinsulinism Hyperammonemia Syndrome
por: Komal, FNU, et al.
Publicado: (2023)

MON-909 Diabetic Ketoacidosis Following Treatment of Endogenous Hyperinsulinism
por: Murari, Keerti, et al.
Publicado: (2020)

Carlo Rubbia: "La recherche c'est mon défaut génétique!"
por: Ruetschi, P
Publicado: (1989)

The Role of GLP-1 Signaling in Hypoglycemia due to Hyperinsulinism
por: Danowitz, Melinda, et al.
Publicado: (2022)

MON-080 Unusual Association Between Congenital Hyperinsulinism and Neurofibromatosis Type 1
por: Marinescu, Andreea S, et al.
Publicado: (2020)

Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient
por: Banerjee, Indraneel, et al.
Publicado: (2017)

Mapping the Alterations of Glutamate Using Glu-Weighted CEST MRI in a Rat Model of Fatigue
por: Li, Ruili, et al.
Publicado: (2020)

A novel mutation in GLUD1 causing hyperinsulinism-hyperammonemia in a patient with high density of homozygosity on microarray: a case report
por: Odom, John, et al.
Publicado: (2016)

Hyperinsulinism
Publicado: (1932)

Imaging of nerve injury in neonatal acute bilirubin encephalopathy using (1)H-MRS and Glu-CEST techniques
por: Lin, Qihuan, et al.
Publicado: (2023)

MON-105 A Case Report of Neonatal Hyperinsulinism in an Infant with Turner Syndrome Successfully Treated with Diazoxide
por: Patterson, Rebecca J, et al.
Publicado: (2020)

Therapy of hyperammonemia
por: Widera, Agata
Publicado: (2015)

C'est toujours non!
por: Anselme, R
Publicado: (1984)

Natural history and neurodevelopmental outcomes in perinatal stress induced hyperinsulinism
por: Sigal, Winnie M., et al.
Publicado: (2022)

Case Report: Two Distinct Focal Congenital Hyperinsulinism Lesions Resulting From Separate Genetic Events
por: Rosenfeld, Elizabeth, et al.
Publicado: (2021)

Hyperammonemia alters membrane expression of GluA1 and GluA2 subunits of AMPA receptors in hippocampus by enhancing activation of the IL-1 receptor: underlying mechanisms
por: Taoro-Gonzalez, Lucas, et al.
Publicado: (2018)

MON-111 Plasma Insulin Measured with a Sensitive Immunoassay May Establish the Diagnosis of Congenital Hyperinsulinism Without Further Testing
por: Siersbæk, Julie, et al.
Publicado: (2020)

The Toll of Hyperammonemia on the Brain
por: Saunders, Justin M., et al.
Publicado: (2019)

Hyperammonemia Due to Empyema
por: Wada, Hiroshi, et al.
Publicado: (2023)

Phenotypic Characterization of Congenital Hyperinsulinism Due to Novel Activating Glucokinase Mutations
por: Li, Changhong, et al.
Publicado: (2023)

GLINT: GlucoCEST in neoplastic tumors at 3 T—clinical results of GlucoCEST in gliomas
por: Bender, Benjamin, et al.
Publicado: (2021)

Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families
por: Banerjee, Indraneel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_agqfuiqt7t7a8t0kcg1lh4ap0a